CN101509028A - Method for orthogenesis with differ-degree continuous-fallibility PCR - Google Patents

Method for orthogenesis with differ-degree continuous-fallibility PCR Download PDF

Info

Publication number
CN101509028A
CN101509028A CNA2009100480205A CN200910048020A CN101509028A CN 101509028 A CN101509028 A CN 101509028A CN A2009100480205 A CNA2009100480205 A CN A2009100480205A CN 200910048020 A CN200910048020 A CN 200910048020A CN 101509028 A CN101509028 A CN 101509028A
Authority
CN
China
Prior art keywords
error
prone pcr
pcr
final concentration
carry out
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2009100480205A
Other languages
Chinese (zh)
Inventor
孟清
周倩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Donghua University
Original Assignee
Donghua University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Donghua University filed Critical Donghua University
Priority to CNA2009100480205A priority Critical patent/CN101509028A/en
Publication of CN101509028A publication Critical patent/CN101509028A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

本发明涉及一种利用不同程度的连续易错PCR进行定向进化的方法,包括:选择目的基因为模板设计引物;配制高、中、低不同程度的d[X]TP易错PCR体系;将配制好的PCR反应体系放入PCR仪中进行PCR扩增;将易错PCR产物通过琼脂糖凝胶电泳回收,进行酶切、与载体连接、转化,进行阳性克隆筛选,提取质粒;以提取的质粒为模板,进行第二轮易错PCR;利用相应筛选系统进行有用突变的筛选。该方法操作简单,操作简单,突变频率高、产量稳定,可为定向进化蛋白质提供新的思路和途径。

Figure 200910048020

The invention relates to a method for directional evolution using continuous error-prone PCR of different degrees, comprising: selecting a target gene as a template to design primers; preparing d[X]TP error-prone PCR systems with different degrees of high, medium and low; A good PCR reaction system is put into a PCR machine for PCR amplification; the error-prone PCR product is recovered by agarose gel electrophoresis, digested, connected with a carrier, transformed, positive clones are screened, and the plasmid is extracted; the extracted plasmid As a template, the second round of error-prone PCR is carried out; the corresponding screening system is used to screen for useful mutations. The method is simple to operate, has high mutation frequency and stable yield, and can provide new ideas and approaches for directed evolution of proteins.

Figure 200910048020

Description

A kind of method of utilizing continuous error-prone PCR of different degrees to carry out orthogenesis
Technical field
The present invention relates to biotechnology protein engineering research field, relate in particular to a kind of method of utilizing continuous error-prone PCR of different degrees to carry out orthogenesis.
Background technology
Orthogenesis (Directed evolution) is the new technology that developed recently gets up, and is extension and the application of Darwinian evolutionsim thought on nucleic acid, peptide or albumen equimolecular level.It does not need to understand in depth proteinic structure-function relationship, manual simulation biomacromolecule nature evolutionary process under laboratory condition, external gene is carried out random mutagenesis, make gene that a large amount of variations take place, and orthoselection goes out the mutant of required character, thereby can realize the evolutionary process that nature just can be finished in millions of years at short notice.
Orthogenesis technology utilization two kinds of technology the most widely is fallibility PCR (error prone PCR) and DNA reorganization (DNAshuffling), its core concept is the gene order that changes coded protein randomly, obtain the library, from the library, obtain the goal gene that forward is evolved by a large amount of screenings then.Wherein fallibility PCR is a kind of easy method of making sudden change apace in dna sequence dna at random, and it is by changing some component concentrations in the conventional P CR reaction system, makes base mispairing and introduce multipoint mutation at random to a certain extent.The key of this kind method is to select suitable mutation frequency, when mutation frequency is too high, almost can't screen useful sudden change; If mutation frequency is too low, wild-type will occupy the advantage of mutagenized populations, also be difficult to screen the ideal mutant.In general, suitable mutation frequency is 2~3 bases of each sequence or 1 amino-acid residue sudden change.Often be difficult to obtain satisfied result because one takes turns fallibility PCR, continuous error-prone PCR method therefore commonly used, the favourable mutator gene that pcr amplification is obtained is as the template of amplification next time, carry out random mutagenesis continuously repeatedly, make each time the micromutation accumulation that obtains and produce important useful sudden change.The present invention has introduced high, medium and low three kinds of fallibility PCR simultaneous mutations in various degree, with the screening sudden change storehouse that reaches specific mutation frequency and obtain some amount.
Summary of the invention
Technical problem to be solved by this invention provides a kind of method of utilizing high, normal, basic continuous error-prone PCR of different degrees rapidly and efficiently to carry out orthogenesis, and this method is by adding the Mg of various dose 2+, Mn 2+, and the interpolation concentration ratio of dATP, dTTP, dCTP, dGTP base in the change system, increase the mispairing rate, simple to operate, mutation frequency height, stable yield can be directed evolution of proteins new thinking and approach are provided.
The method of utilizing continuous error-prone PCR of different degrees to carry out orthogenesis provided by the present invention comprises the steps:
(7) selecting goal gene is template design primer;
(8) the high, medium and low d[X in various degree of preparation] the TP error-prone PCR systems;
(9) prepared PCR reaction system is put into the PCR instrument and carried out pcr amplification;
(10) fallibility PCR product is reclaimed by agarose gel electrophoresis, carry out enzyme and cut, be connected, transform, carry out the positive colony screening, extract plasmid with carrier;
(11) be template with the plasmid that extracts, repeating step (1)~(4) are carried out second and are taken turns fallibility PCR;
(12) repeating step (5) utilizes corresponding screening system to carry out the screening of useful sudden change.
In the error-prone PCR systems of the described low degree such as sudden change such as grade of step (2): 25mmol/L Mg 2+Final concentration be 0.25mmol/L, 5mmol/L Mn 2+Final concentration be 0.05mmol/L, 10mmol/L d[X] final concentration of TP is 1000 μ mol/L.
In the error-prone PCR systems of the described medium sudden change degree of step (2): 25mmol/L Mg 2+Final concentration be 0.5mmol/L, 5mmol/LMn 2+Final concentration be 0.1mmol/L, 10mmol/L d[X] final concentration of TP is 1500 μ mol/L.
In the error-prone PCR systems of the described high sudden change degree of step (2): 25mmol/L Mg 2+Final concentration be 1.0mmol/L, 5mmol/L Mn 2+Final concentration be 0.2mmol/L, 10mmol/L d[X] final concentration of TP is 2000 μ mol/L.
In the described PCR system of step (2), used polysaccharase is the Taq enzyme.
The described PCR reaction conditions of step (3) is: 94 ℃ of sex change in 3 minutes and enzyme activate, 94 ℃ of sex change in 45 seconds, and 58 ℃ of annealing in 30 seconds 30 seconds, 72 ℃ were extended in 90 seconds, circulated 35 times; Last 72 ℃ of extensions in 10 minutes.
TBE buffer is used in the described agarose gel electrophoresis analysis of step (4), and gum concentration is 1.0%, and gel reclaims test kit and uses Qiagen company product.
The present invention utilizes high, normal, basic three kinds of methods of continuous error-prone PCR in various degree, can effectively control mutation frequency, obtains a certain size sudden change storehouse.The present invention is simple to operate, the mutation frequency height, and stable yield, controllability is strong, in conjunction with corresponding screening means, for the orthogenesis engineered protein provides new thinking and approach.
Description of drawings
The fallibility PCR agarose gel electrophoresis result of Fig. 1 embodiment 1, M is marker, the positive contrast of P;
The western blot of Fig. 2 embodiment 2 detects mutant montage activity,
1 negative contrast, 2 positive contrasts, 3~9 is the mutein intron of preliminary screening.
Embodiment
Below in conjunction with specific embodiment, further set forth the present invention.Should be understood that these embodiment only to be used to the present invention is described and be not used in and limit the scope of the invention.Should be understood that in addition those skilled in the art can make various changes or modifications the present invention after the content of having read the present invention's instruction, these equivalent form of values fall within the application's appended claims institute restricted portion equally.
Embodiment 1: the orthogenesis of protein intron
1. select the protein intron Ssp DnaB of montage active about 30% to carry out fallibility PCR, the design primer is as follows:
5’-AGTCACCGGTTAAGCAAGTACAAACAGGAATCGAATGC-3
5’-TGGCTTACTAGTCCATAACTGTCCTTTTAACAGCGATCGC-3’
2. following reagent places on ice, by the low d[X that waits the sudden change degree of preparation in the PCR pipe that fills a prescription] TP error-prone PCR systems 4 pipes:
10×PCR?buffer 5μl
dNTPs 4μl(250μmol/L?each)
Primer?1 1μl(0.5μmol/L)
Primer?2 1μl(0.5μmol/L)
Template 1μl(60ng)
Taq 1μl(5U)
25mmol/L?Mg 2+ 0.5μl(0.25mmol/L)
5mmol/LMn 2+ 0.5μl(0.05mmol/L)
10mmol/Ld[X]TP 5μl(1000μmol/L)
ddH 2O To?50μl
3. following reagent places on ice, prepares the d[X of medium sudden change degree by following the prescription in the PCR pipe] TP error-prone PCR systems 4 pipes:
10×PCR?buffer 5μl
dNTPs 4μl(250μmol/L?each)
Primer?1 1μl(0.5μmol/L)
Primer?2 1μl(0.5μmol/L)
Template 1μl(60ng)
Taq 1μl(5U)
25mmol/L?Mg 2+ 1μl(0.5mmol/L)
5mmol/L?Mn 2+ 1μl(0.1mmol/L)
10mmol/L?d[X]TP 7.5μl(1500μmol/L)
ddH 2O To?50μl
4. following reagent places on ice, prepares the d[X of high sudden change degree by following the prescription in the PCR pipe] TP error-prone PCR systems 4 pipes:
10×PCR?buffer 5μl
dNTPs 4μl(250μmol/L?each)
Primer?1 1μl(0.5μmol/L)
Primer?2 1μl(0.5μmol/L)
Template 1μl(60ng)
Taq 1μl(5U)
25mmol/L?Mg 2+ 2μl(1.0mmol/L)
5mmol/L?Mn 2+ 2μl(0.2mmol/L)
10mmol/L?d[X]TP 10μl(2000μmol/L)
ddH 2O To?50μl
5. above-mentioned 12 pipe prepared PCR reaction system are put into the PCR instrument, press following program setting:
Figure A200910048020D00061
6. fallibility PCR product is mixed by agarose gel electrophoresis (Fig. 1), recovery back and put into 1.5ml EP pipe, the following reagent that thaws on ice utilizes following system to cut 5h at 37 ℃ of enzymes.
Figure A200910048020D00062
7. utilize following system to spend the night in 16 ℃ and connect among the carrier pKH6b that enzyme cuts, coat the kalamycin resistance flat board behind the Transformed E .coli DH5 α, the picking positive colony extracts plasmid.
Figure A200910048020D00063
8. be template with the plasmid that extracts, repeating step 1~7 carries out second and takes turns fallibility PCR.
9. utilize western blot, use the test kit of mouse anti His antibody and invitrogen company, detect the montage activity of the mutein intron that screens.
5. experimental result (Fig. 2)
Through dull and stereotyped preliminary screening to the 7 positive mutant of kalamycin resistance, utilize western blot further to detect as can be known, the protein intron sample 3 that four sudden changes are arranged, 4,6,7 montage activity reach more than 90%, prove successfully to utilize fallibility PCR orthogenesis in various degree to obtain the active protein intron of high montage.

Claims (8)

1.一种利用不同程度的连续易错PCR进行定向进化的方法,其特征在于包括如下步骤:1. A method utilizing continuous error-prone PCR in various degrees to carry out directed evolution is characterized in that comprising the steps: (1)选择目的基因为模板设计引物;(1) Select the target gene as a template to design primers; (2)配制高、中、低不同程度的d[X]TP易错PCR体系;(2) Prepare d[X]TP error-prone PCR systems with different degrees of high, medium and low; (3)将配制好的PCR反应体系放入PCR仪中进行PCR扩增;(3) Putting the prepared PCR reaction system into a PCR instrument for PCR amplification; (4)将易错PCR产物通过琼脂糖凝胶电泳回收,进行酶切、与载体连接、转化,进行阳性克隆筛选,提取质粒,(4) The error-prone PCR product is recovered by agarose gel electrophoresis, digested, connected to the carrier, transformed, screened for positive clones, and the plasmid is extracted, (5)以提取的质粒为模板,重复步骤(1)~(4)进行第二轮易错PCR;(5) Using the extracted plasmid as a template, repeat steps (1) to (4) to carry out the second round of error-prone PCR; (6)重复步骤(5),利用相应筛选系统进行有用突变的筛选。(6) Step (5) is repeated, and the corresponding screening system is used to screen useful mutations. 2.根据权利要求1所述的一种利用不同程度的连续易错PCR进行定向进化的方法,其特征在于:步骤(2)所述的低等突变程度的易错PCR体系中:25mmol/L Mg2+的终浓度为0.25mmol/L,5mmol/L Mn2+的终浓度为0.05mmol/L,10mmol/L d[X]TP的终浓度为1000μmol/L。2. a kind of method utilizing different degrees of continuous error-prone PCR to carry out directed evolution according to claim 1, is characterized in that: in the error-prone PCR system of the described low mutation degree of step (2): 25mmol/L The final concentration of Mg 2+ is 0.25mmol/L, the final concentration of 5mmol/L Mn 2+ is 0.05mmol/L, and the final concentration of 10mmol/L d[X]TP is 1000μmol/L. 3.根据权利要求1所述的一种利用不同程度的连续易错PCR进行定向进化的方法,其特征在于:步骤(2)所述的中等突变程度的易错PCR体系中:25mmol/L Mg2+的终浓度为0.5mmol/L,5mmol/L Mn2+的终浓度为0.1mmol/L,10mmol/L d[X]TP的终浓度为1500μmol/L。3. a kind of method utilizing different degrees of continuous error-prone PCR to carry out directed evolution according to claim 1, is characterized in that: in the error-prone PCR system of the described medium degree of mutation of step (2): 25mmol/L Mg The final concentration of 2+ is 0.5mmol/L, the final concentration of 5mmol/L Mn 2+ is 0.1mmol/L, and the final concentration of 10mmol/L d[X]TP is 1500μmol/L. 4.根据权利要求1所述的一种利用不同程度的连续易错PCR进行定向进化的方法,其特征在于:步骤(2)所述的高等突变程度的易错PCR体系中:25mmol/L Mg2+的终浓度为1.0mmol/L,5mmol/L Mn2+的终浓度为0.2mmol/L,10mmol/L d[X]TP的终浓度为2000μmol/L。4. a kind of method utilizing different degrees of continuous error-prone PCR to carry out directed evolution according to claim 1, is characterized in that: in the error-prone PCR system of the high degree of mutation described in step (2): 25mmol/L Mg The final concentration of 2+ is 1.0mmol/L, the final concentration of 5mmol/L Mn 2+ is 0.2mmol/L, and the final concentration of 10mmol/L d[X]TP is 2000μmol/L. 5.根据权利要求1-4之一所述的一种利用不同程度的连续易错PCR进行定向进化的方法,其特征在于:所用聚合酶为Taq酶。5. A method for directed evolution using different degrees of continuous error-prone PCR according to any one of claims 1-4, characterized in that: the polymerase used is Taq enzyme. 6.根据权利要求1所述的一种利用不同程度的连续易错PCR进行定向进化的方法,其特征在于:步骤(3)所述的PCR反应条件为:94℃3分钟变性和酶激活,94℃45秒变性,58℃30秒30秒退火,72℃90秒延伸,循环35次;最后72℃10分钟延伸。6. A method for directional evolution utilizing continuous error-prone PCR of varying degrees according to claim 1, characterized in that: the PCR reaction conditions described in step (3) are: denaturation and enzyme activation for 3 minutes at 94°C, Denaturation at 94°C for 45 seconds, annealing at 58°C for 30 seconds and 30 seconds, extension at 72°C for 90 seconds, and 35 cycles; finally, extension at 72°C for 10 minutes. 7.根据权利要求1所述的一种利用不同程度的连续易错PCR进行定向进化的方法,其特征在于:步骤(1)所述的引物以蛋白质内含子Ssp DnaB的基因为模板设计,引物如下:7. a kind of method that utilizes the continuous error-prone PCR of varying degrees to carry out directed evolution according to claim 1, is characterized in that: the primer described in step (1) is template design with the gene of intein Ssp DnaB, Primers are as follows: 引物1 5’-AGTCACCGGTTAAGCAAGTACAAACAGGAATCGAATGC-3Primer 1 5'-AGTCACCGGTTAAGCAAGTACAAACAGGAATCGAATGC-3 引物2 5’-TGGCTTACTAGTCCATAACTGTCCTTTTAACAGCGATCGC-3’Primer 2 5'-TGGCTTACTAGTCCATAACTGTCCTTTTAACAGCGATCGC-3' 8.根据权利要求7所述的一种利用不同程度的连续易错PCR进行定向进化的方法,其特征在于:所述的酶切位点为:Spe I与Age I;连接载体为pKH6b;筛选系统为卡那霉素抗性平板。8. a kind of method utilizing different degrees of continuous error-prone PCR to carry out directional evolution according to claim 7, is characterized in that: described enzyme cutting site is: Spe I and Age I; Connection carrier is pKH6b; Screening The system is a kanamycin resistant plate.
CNA2009100480205A 2009-03-23 2009-03-23 Method for orthogenesis with differ-degree continuous-fallibility PCR Pending CN101509028A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2009100480205A CN101509028A (en) 2009-03-23 2009-03-23 Method for orthogenesis with differ-degree continuous-fallibility PCR

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2009100480205A CN101509028A (en) 2009-03-23 2009-03-23 Method for orthogenesis with differ-degree continuous-fallibility PCR

Publications (1)

Publication Number Publication Date
CN101509028A true CN101509028A (en) 2009-08-19

Family

ID=41001560

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2009100480205A Pending CN101509028A (en) 2009-03-23 2009-03-23 Method for orthogenesis with differ-degree continuous-fallibility PCR

Country Status (1)

Country Link
CN (1) CN101509028A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101870984A (en) * 2010-05-28 2010-10-27 浙江大学 The RSP_2728 esterase mutant gene obtained by directed evolution and the application of esterase in the splitting reaction of methyl mandelate
CN102345172A (en) * 2010-07-30 2012-02-08 中国农业科学院植物保护研究所 Method for establishing mutant library with controllable mutation rate, and application thereof
CN108546697A (en) * 2018-04-08 2018-09-18 浙江华睿生物技术有限公司 Enzyme process prepares beta alanine

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101870984A (en) * 2010-05-28 2010-10-27 浙江大学 The RSP_2728 esterase mutant gene obtained by directed evolution and the application of esterase in the splitting reaction of methyl mandelate
CN101870984B (en) * 2010-05-28 2012-06-13 浙江大学 RSP_2728 esterase mutant genes obtained by directed evolution and application of esterase in methyl mandelate resolution reaction
CN102345172A (en) * 2010-07-30 2012-02-08 中国农业科学院植物保护研究所 Method for establishing mutant library with controllable mutation rate, and application thereof
CN102345172B (en) * 2010-07-30 2014-05-07 中国农业科学院植物保护研究所 Method for establishing mutant library with controllable mutation rate, and application thereof
CN108546697A (en) * 2018-04-08 2018-09-18 浙江华睿生物技术有限公司 Enzyme process prepares beta alanine
CN108546697B (en) * 2018-04-08 2020-07-24 浙江华睿生物技术有限公司 Enzyme method for preparing beta alanine

Similar Documents

Publication Publication Date Title
US20210363570A1 (en) Method for increasing throughput of single molecule sequencing by concatenating short dna fragments
CN111139532B (en) Method and kit for simultaneously constructing sequencing library by DNA and RNA
JP6982087B2 (en) Building a Next Generation Sequencing (NGS) Library Utilizing Competitive Chain Substitution
US20150050658A1 (en) Gene shuffling methods
WO2015144045A1 (en) Plasmid library comprising two random markers and use thereof in high throughput sequencing
CN113136376A (en) A Cas12a variant and its application in gene editing
CN101509028A (en) Method for orthogenesis with differ-degree continuous-fallibility PCR
EP3436471B1 (en) Recombinase mutants
US9834762B2 (en) Modified polymerases for replication of threose nucleic acids
EP4352233A1 (en) Crispr-transposon systems for dna modification
US6955879B2 (en) Method for generating recombinant DNA library using unidirectional single-stranded DNA fragments
EP3676396B1 (en) Transposase compositions, methods of making and methods of screening
CN104805508B (en) A kind of method based on synthesizing single-stranded DNA library evolution metabolic pathway
CN114901820A (en) Method for constructing gene mutation library
EP2261332A2 (en) Libraries of recombinant chimeric proteins
JP2005512578A (en) PCR-based highly efficient polypeptide screening
CN105255858A (en) Method for transforming nucleic acid genotype
CN106916883A (en) Method and the application of large fragment deletion gene are detected on Single base extension technology platform
CN101532181A (en) Method and kit for in-situ construction of gene mutation library
CN101532043A (en) New gene mutation recombination method and application thereof
Escudero García-Calderón et al. Primary and promiscuous functions coexist during evolutionary innovation through whole protein domain acquisitions
Pompon et al. Sequence Mapping of Combinatorial Libraries on Macro-and Microarrays
CN116355939A (en) A plasmid suitable for Streptomyces cell-free protein synthesis system and its construction method and application
CN119162318A (en) Method for analyzing tumor cell CIN epigenetic characteristics
CN119082272A (en) Nucleic acid detection method based on engineered Cas12b and sgRNA backbone

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20090819